Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

€3.03

SKU: product-article-18799 Category: General

Description
Reviews (0)

Description

Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

Reviews

There are no reviews yet.

Be the first to review “Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression”

You must be logged in to post a review.

Top

Article: Adding elotuzumab to standard treatment for multiple myeloma delays disease progression

Description

Reviews

Related products

Article: Calendar of events

Article: INTRODUCTION

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in squamous cell carcinoma of the head and neck